News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,536 Results
Type
Article (33332)
Company Profile (720)
Press Release (632475)
Multimedia
Podcasts (90)
Webinars (19)
Section
Business (196888)
Career Advice (2116)
Deals (36243)
Drug Delivery (119)
Drug Development (77775)
Employer Resources (164)
FDA (15357)
Job Trends (14680)
News (331853)
Policy (28647)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1249)
Academic (1)
Accelerated approval (29)
Adcomms (20)
Allergies (136)
Alliances (46779)
ALS (171)
Alzheimer's disease (1573)
Antibody-drug conjugate (ADC) (305)
Approvals (15586)
Artificial intelligence (509)
Autoimmune disease (155)
Automation (32)
Bankruptcy (376)
Best Places to Work (10813)
BIOSECURE Act (23)
Biosimilars (178)
Biotechnology (444)
Bladder cancer (142)
Brain cancer (52)
Breast cancer (558)
Cancer (4455)
Cardiovascular disease (384)
Career advice (1766)
Career pathing (37)
CAR-T (271)
CDC (19)
Celiac Disease (1)
Cell therapy (738)
Cervical cancer (31)
Clinical research (67012)
Collaboration (1706)
Company closure (4)
Compensation (1141)
Complete response letters (68)
COVID-19 (2276)
CRISPR (87)
C-suite (861)
Cystic fibrosis (144)
Data (5948)
Decentralized trials (2)
Denatured (8)
Depression (137)
Diabetes (458)
Diagnostics (6578)
Digital health (42)
Diversity (6)
Diversity, equity & inclusion (38)
Drug discovery (242)
Drug pricing (190)
Drug shortages (27)
Duchenne muscular dystrophy (220)
Earnings (86421)
Editorial (52)
Employer branding (24)
Employer resources (144)
Events (114087)
Executive appointments (996)
FDA (18331)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1421)
Gene editing (199)
Generative AI (47)
Gene therapy (585)
GLP-1 (973)
Government (3027)
Grass and pollen (8)
Guidances (372)
Healthcare (15835)
HIV (52)
Huntington's disease (48)
IgA nephropathy (82)
Immunology and inflammation (265)
Immuno-oncology (58)
Indications (99)
Infectious disease (2527)
Inflammatory bowel disease (185)
Inflation Reduction Act (13)
Influenza (108)
Intellectual property (247)
Interviews (428)
IPO (17321)
IRA (49)
Job creations (4216)
Job search strategy (1441)
JPM (59)
Kidney cancer (14)
Labor market (80)
Layoffs (629)
Leadership (33)
Legal (7132)
Liver cancer (88)
Longevity (13)
Lung cancer (586)
Lymphoma (340)
Machine learning (41)
Management (59)
Manufacturing (793)
MASH (164)
Medical device (13869)
Medtech (13923)
Mergers & acquisitions (19986)
Metabolic disorders (1230)
Multiple sclerosis (154)
NASH (18)
Neurodegenerative disease (318)
Neuropsychiatric disorders (96)
Neuroscience (2800)
Neurotech (1)
NextGen: Class of 2026 (5951)
Non-profit (1874)
Now hiring (66)
Obesity (592)
Opinion (291)
Ovarian cancer (148)
Pain (200)
Pancreatic cancer (222)
Parkinson's disease (278)
Partnered (33)
Patents (494)
Patient recruitment (478)
Peanut (57)
People (58103)
Pharmaceutical (134)
Pharmacy benefit managers (27)
Phase 1 (21155)
Phase 2 (29948)
Phase 3 (22096)
Pipeline (5008)
Policy (264)
Postmarket research (1898)
Preclinical (8508)
Press Release (64)
Prostate cancer (229)
Psychedelics (51)
Radiopharmaceuticals (291)
Rare diseases (832)
Real estate (5725)
Recruiting (68)
Regulatory (22607)
Reports (40)
Research institute (1316)
Resumes & cover letters (332)
Rett syndrome (25)
RNA editing (16)
RSV (73)
Schizophrenia (151)
Series A (254)
Series B (195)
Service/supplier (26)
Sickle cell disease (96)
Special edition (25)
Spinal muscular atrophy (155)
Sponsored (29)
Startups (3909)
State (2)
Stomach cancer (16)
Supply chain (101)
Tariffs (96)
The Weekly (81)
Vaccines (913)
Venture capital (95)
Weight loss (393)
Women's health (69)
Worklife (21)
Date
Last 7 days (611)
Last 30 days (2111)
Last 365 days (29921)
2026 (2860)
2025 (30314)
2024 (35462)
2023 (40199)
2022 (50318)
2021 (53447)
2020 (50463)
2019 (41628)
2018 (31834)
2017 (32294)
2016 (30392)
2015 (35792)
2014 (28459)
2013 (23445)
2012 (25029)
2011 (25202)
2010 (23090)
Location
Africa (676)
Alabama (91)
Alaska (6)
Arizona (224)
Arkansas (11)
Asia (41150)
Australia (6711)
California (11213)
Canada (3202)
China (1123)
Colorado (466)
Connecticut (476)
Delaware (311)
Europe (90117)
Florida (1598)
Georgia (342)
Hawaii (4)
Idaho (58)
Illinois (742)
India (67)
Indiana (529)
Iowa (23)
Japan (390)
Kansas (120)
Kentucky (38)
Louisiana (24)
Maine (76)
Maryland (1206)
Massachusetts (8255)
Michigan (328)
Minnesota (630)
Mississippi (4)
Missouri (126)
Montana (33)
Nebraska (25)
Nevada (120)
New Hampshire (82)
New Jersey (2959)
New Mexico (31)
New York (2877)
North Carolina (1522)
North Dakota (8)
Northern California (5474)
Ohio (307)
Oklahoma (18)
Oregon (47)
Pennsylvania (2206)
Puerto Rico (22)
Rhode Island (47)
South America (1062)
South Carolina (64)
South Dakota (1)
Southern California (4266)
Tennessee (140)
Texas (1689)
United States (39300)
Utah (320)
Vermont (1)
Virginia (254)
Washington D.C. (75)
Washington State (926)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
666,536 Results for "perrigo company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations
November 5, 2025
·
66 min read
Press Releases
Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations
August 6, 2025
·
63 min read
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 11th at 1:30 PM EDT.
May 28, 2024
·
1 min read
Business
Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024
Perrigo Company plc today announced that it plans to issue its fourth quarter and fiscal year 2023 financial results on Tuesday, February 27th , 2024 and will host a conference call beginning at 8:30 A.M. (EST).
February 13, 2024
·
2 min read
Business
Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program
Perrigo Company plc announced financial results from continuing operations for the fourth quarter and fiscal year ended December 31, 2023.
February 27, 2024
·
63 min read
FDA
Perrigo’s Opill Gets FDA Approval as First OTC Oral Contraceptive in US
The regulator on Thursday approved Opill, the first oral contraceptive available in the U.S. without a prescription. Perrigo shares rose 6% in response to the news.
July 13, 2023
·
2 min read
·
Rosemary Scott
Job Trends
10 Companies Hiring IT Professionals Now
Looking for an IT job? From data engineer to information security, check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
January 29, 2026
·
2 min read
·
Angela Gabriel
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 5, 2026
·
1 min read
·
Angela Gabriel
FDA
FDA Advisory Panel Strongly Backs Perrigo’s OTC Birth Control Pill
The joint committee of external experts voted unanimously in favor of Perrigo, finding that the benefits of allowing non-prescription use of the birth control tablet Opill outweigh its risks.
May 11, 2023
·
2 min read
·
Tristan Manalac
Job Trends
11 Companies Hiring Manufacturing Professionals Now
Looking for a manufacturing job? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
January 15, 2026
·
2 min read
·
Angela Gabriel
1 of 66,654
Next
